Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2014

Aug 21, 2014

35081_dirs_2014-08-21_f96e7329-b477-4dfa-b473-29ed8ec6db13.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tiger X Medical, Inc. (CDOM)
CIK: 0000925741
Period of Report: 2014-08-20

Reporting Person: FROST PHILLIP MD ET AL (10% Owner)
Reporting Person: Frost Gamma Investments Trust (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-20 Common Stock, $0.001 par value P 50000 $0.1022 Acquired 34072777 Indirect
2014-08-20 Common Stock, $0.001 par value P 50000 $0.103 Acquired 34122777 Indirect

Footnotes

F1: These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder.